Deficient Method Validations, Aseptic ar
Cipla facility at Verna, Goa was audited by USFDA during June 2024 ending with issuance
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Cipla facility at Verna, Goa was audited by USFDA during June 2024 ending with issuance
Aurobindo arm Eugia Pharma site at Sangareddy, Telengana was inspected by USFDA in Jan -Feb
Biocon Malaysia was inspected by USFDA Investigators Eileen A. Liu, Patty P. Kaewussdangkul, Daniel Lahar,
USFDA 483 / Lupin, Pithampur, India / FEI 3007549629/ Inspection Mar 21 – Mar 29, 2023
USFDA 483 to Lupin Pithampur in Mar 2023 (Inspectors Eileen A Liu, Yvins Dezan) cites
USFDA 483 to Lupin Pithampur in Mar 2023 (Inspectors Eileen A Liu, Yvins Dezan) cites deficiencies